Randomized controlled trial to examine the influence to vascular endothelial function by eradicating Helicobacter pylori in patients with coronary heart disease

Randomized controlled trial to examine the influence to vascular endothelial function by eradicating Helicobacter pylori in patients with coronary heart disease - Randomized controlled trial of the impact of Helicobacter pylori eradication in coronary heart disease patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020483

Enrollment

Registered

2016-01-07

Start date

2016-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease Helicobacter pylori infection

Interventions

eradication of Helicobacter pylori not eradication of Helicobacter pylori

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with coronary heart disease requiring percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: 1) Past history of eradication for Helicobacter pylori 2) End stage renal failure on hemodialysis 3) Hemodynamically unstable condition

Design outcomes

Primary

Measure	Time frame
vascular endothelial function	—

Secondary

Measure	Time frame
cardiovascular events inflammatory markers oxidative stress	—

Countries

Japan

Contacts

Public ContactSeiji Hokimoto

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

shokimot@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026